In glioblastoma patients pre-RT, the mean ± SD of serum VEGF was 1790 ± 591.7 that was increased to 2529.4 ± 736.5 post-RT, while it was 790.2 ± 147.4 in healthy controls. This evidence concerns the gene VEGFA and glioblastoma.